Video | Agriculture | Confidence | Economy | Energy | Employment | Finance | Media | Property | RBNZ | Science | SOEs | Tax | Technology | Telecoms | Tourism | Transport | Search


Pacific Edge’s half year report

Please find attached Pacific Edge’s half year report


Highlights and Key Events

• Signed Cxbaldder agreement with Multiplan, a large National Provider Network (NPN) in the US. This is the fourth agreement to be signed with NPNs since October 2013.

• Signed User Programme agreement with Southern California Permanente Medical Group (SCPMG) to trial and evaluate Cxbladder within the clinical settings of Kaiser Permanente’s health care network.

• Expanded US sales team from four to twelve members.

• Launched ecommerce platform in New Zealand, making Cxbladder test easily accessible by New Zealand urologists, physicians and patients.

• Successfully completed two validation studies with the Waitemata and Canterbury District Health Boards with results supporting clinical study findings.

• Signed agreements with Urologists servicing the Bay of Plenty and Lakes District Health Boards.

• Continuing to work with National Health Council to put Cxbladder into the Standard of Care in New Zealand.

• Pacific Edge granted US patent for melanoma prognostic technology in the US.

• Pacific Edge granted patent in Japan for colorectal cancer prognostic technology.

• Named NZBIO’s top Bioscience company for 2014 for building the profile and credibility of biotechnology and biotechnology companies in New Zealand.

• Continuing the refresh of the Pacific Edge Board with the resignation of Colin Dawson following the 2014 annual meeting and the appointment of Charles Sitch as an independent director, effective from 1 November 2014.

CEO, David Darling was appointed as Executive Director at the annual meeting.

Post-period end:

• Announced appointment of Kate Rankin as Chief Financial Officer.

• Launched Cxbladder Triage in New Zealand and Australia, providing a new tool for urologists and clinicians to triage out patients presenting with haematuria who have a low probability of having bladder cancer.


© Scoop Media

Business Headlines | Sci-Tech Headlines


Commerce Commission: Mercury Cleared To Acquire Trustpower’s Retail Business

The Commerce Commission has granted clearance for Mercury NZ Limited to acquire Trustpower Limited’s retail business. Deputy Chair Sue Begg said the Commission is satisfied that the acquisition is unlikely to substantially lessen competition in any New Zealand market.... More>>

Consumer NZ: Buy-now, Pay-later Raking In $10m+ In Late Fees Annually

A Consumer NZ survey has found buy-now, pay-later services are costing shoppers more than $10 million a year in late fees. Close to four out of 10 Kiwi consumers use buy-now, pay-later services, such as Afterpay, Laybuy and Zip... More>>

Westpac: Catherine Mcgrath Appointed New Zealand CEO

Westpac Group CEO Peter King and the Westpac New Zealand Board today announced the appointment of Catherine McGrath as Chief Executive Officer, Westpac New Zealand... More>>

Statistics: Surge In Imports Results In Record Monthly Trade Deficit
Imports increased $1.8 billion in August 2021 compared with August 2020, resulting in a record monthly trade deficit of $2.1 billion, Stats NZ said today. Exports were little changed, down $42 million. "This is a larger deficit than normal because of higher values for imports.. More>>

Fonterra: Completes reset, announces annual results and long-term growth plan out to 2030

Fonterra Co-operative Group Limited today announced a strong set of results for the 2021 financial year, reflected in a final Farmgate Milk Price of $7.54, normalised earnings per share of 34 cents and a final dividend of 15 cents... More>>

Statistics: GDP rises in the June 2021 quarter

Gross domestic product (GDP) rose by 2.8 percent in the June 2021 quarter, following a 1.4 percent increase in the March 2021 quarter, Stats NZ said today. June 2021 quarter GDP was 4.3 percent higher when compared with the December 2019 quarter... More>>